Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma.

Taiana E, Favasuli V, Ronchetti D, Todoerti K, Pelizzoni F, Manzoni M, Barbieri M, Fabris S, Silvestris I, Gallo Cantafio ME, Platonova N, Zuccalà V, Maltese L, Soncini D, Ruberti S, Cea M, Chiaramonte R, Amodio N, Tassone P, Agnelli L, Neri A.

Leukemia. 2019 Aug 19. doi: 10.1038/s41375-019-0542-5. [Epub ahead of print]

PMID:
31427718
2.

Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.

Iurlo A, Elli EM, Palandri F, Cattaneo D, Bossi A, Cortinovis I, Bucelli C, Orofino N, Brioschi F, Auteri G, Bianchi P, Fabris S, Isimbaldi G, Sabattini E, Baldini L, Gianelli U.

Hematol Oncol. 2019 Jul 29. doi: 10.1002/hon.2658. [Epub ahead of print]

PMID:
31359447
3.

The Role of New Technologies in Myeloproliferative Neoplasms.

Palumbo GA, Stella S, Pennisi MS, Pirosa C, Fermo E, Fabris S, Cattaneo D, Iurlo A.

Front Oncol. 2019 Apr 26;9:321. doi: 10.3389/fonc.2019.00321. eCollection 2019. Review.

4.

Membrane Lipid-KIR2.x Channel Interactions Enable Hemodynamic Sensing in Cerebral Arteries.

Sancho M, Fabris S, Hald BO, Brett SE, Sandow SL, Poepping TL, Welsh DG.

Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1072-1087. doi: 10.1161/ATVBAHA.119.312493.

PMID:
31043073
5.

The experiences of patients electrically shocked by an implantable cardioverter defibrillator: findings from a descriptive qualitative study.

Palese A, Cracina A, Purino M, Urli N, Fabris S, Danielis M.

Nurs Crit Care. 2019 Apr 17. doi: 10.1111/nicc.12424. [Epub ahead of print]

PMID:
30993838
6.

[The 'Back to the Basics' movement: return to the past or sign of a 'mature' nursing?]

Palese A, Mattiussi E, Fabris S, Caruzzo BD, Achil I.

Assist Inferm Ric. 2019 Jan-Mar;38(1):49-52. doi: 10.1702/3129.31110. Italian. No abstract available.

PMID:
30933192
7.

Fast determination of extra-virgin olive oil acidity by voltammetry and Partial Least Squares regression.

Baldo MA, Oliveri P, Fabris S, Malegori C, Daniele S.

Anal Chim Acta. 2019 May 16;1056:7-15. doi: 10.1016/j.aca.2018.12.050. Epub 2019 Jan 4.

PMID:
30797462
8.

Plasma Activation of Copper Nanowires Arrays for Electrocatalytic Sensing of Nitrate in Food and Water.

Stortini AM, Fabris S, Saorin G, Verga Falzacappa E, Moretto LM, Ugo P.

Nanomaterials (Basel). 2019 Jan 25;9(2). pii: E150. doi: 10.3390/nano9020150.

9.

IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia.

Reda G, Cassin R, Gentile M, Mauro FR, Giannarelli D, Fattizzo B, Barbieri M, Silvestris I, Fabris S, Morabito F, Neri A, Barcellini W, Cortelezzi A.

Leukemia. 2019 Jun;33(6):1519-1522. doi: 10.1038/s41375-018-0344-1. Epub 2019 Jan 11. No abstract available.

PMID:
30635629
10.

Heterogeneous reactions of SO2 on the hematite(0001) surface.

Zhao H, Sheng X, Fabris S, Salahub DR, Sun T, Du L.

J Chem Phys. 2018 Nov 21;149(19):194703. doi: 10.1063/1.5037847.

PMID:
30466267
11.

Global methylation patterns in primary plasma cell leukemia.

Todoerti K, Calice G, Trino S, Simeon V, Lionetti M, Manzoni M, Fabris S, Barbieri M, Pompa A, Baldini L, Bollati V, Zoppoli P, Neri A, Musto P.

Leuk Res. 2018 Oct;73:95-102. doi: 10.1016/j.leukres.2018.09.007. Epub 2018 Sep 18.

PMID:
30257227
12.

The effects of adenine nucleotide perfusion on interstitial adenosine production in rat skeletal muscle.

Zhao Y, Fabris S, MacLean DA.

Can J Physiol Pharmacol. 2018 Aug;96(8):823-829. doi: 10.1139/cjpp-2017-0347. Epub 2018 Apr 10.

PMID:
29633626
13.

Doxorubicin chemotherapy affects the intracellular and interstitial free amino acid pools in skeletal muscle.

Fabris S, MacLean DA.

PLoS One. 2018 Apr 4;13(4):e0195330. doi: 10.1371/journal.pone.0195330. eCollection 2018.

14.

Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias.

Gerber B, Manzoni M, Spina V, Bruscaggin A, Lionetti M, Fabris S, Barbieri M, Ciceri G, Pompa A, Forestieri G, Lerch E, Servida P, Bertoni F, Zucca E, Ghielmini M, Cortelezzi A, Cavalli F, Stussi G, Baldini L, Rossi D, Neri A.

Haematologica. 2018 Jun;103(6):e245-e248. doi: 10.3324/haematol.2017.184358. Epub 2018 Feb 22. No abstract available.

15.

Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence.

Cutrona G, Tripodo C, Matis S, Recchia AG, Massucco C, Fabbi M, Colombo M, Emionite L, Sangaletti S, Gulino A, Reverberi D, Massara R, Boccardo S, de Totero D, Salvi S, Cilli M, Pellicanò M, Manzoni M, Fabris S, Airoldi I, Valdora F, Ferrini S, Gentile M, Vigna E, Bossio S, De Stefano L, Palummo A, Iaquinta G, Cardillo M, Zupo S, Cerruti G, Ibatici A, Neri A, Fais F, Ferrarini M, Morabito F.

Sci Transl Med. 2018 Feb 14;10(428). pii: eaal1571. doi: 10.1126/scitranslmed.aal1571.

PMID:
29444977
16.

Self-texturizing electronic properties of a 2-dimensional GdAu2 layer on Au(111): the role of out-of-plane atomic displacement.

Correa A, Camellone MF, Barragan A, Kumar A, Cepek C, Pedio M, Fabris S, Vitali L.

Nanoscale. 2017 Nov 16;9(44):17342-17348. doi: 10.1039/c7nr04699e.

PMID:
29094126
17.

An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review.

Orofino N, Cattaneo D, Bucelli C, Pettine L, Fabris S, Gianelli U, Fracchiolla NS, Cortelezzi A, Iurlo A.

Leuk Res Rep. 2017 Jul 27;8:7-10. doi: 10.1016/j.lrr.2017.07.002. eCollection 2017.

18.

Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.

Magnani L, Frigè G, Gadaleta RM, Corleone G, Fabris S, Kempe MH, Vershure PJ, Barozzi I, Vircillo V, Hong SP, Perone Y, Saini M, Trumpp A, Viale G, Neri A, Ali S, Colleoni MA, Pruneri G, Minucci S.

Nat Genet. 2017 May 26;49(6):970. doi: 10.1038/ng0617-970b. No abstract available.

19.

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.

Magnani L, Frige G, Gadaleta RM, Corleone G, Fabris S, Kempe MH, Verschure PJ, Barozzi I, Vircillo V, Hong SP, Perone Y, Saini M, Trumpp A, Viale G, Neri A, Ali S, Colleoni MA, Pruneri G, Minucci S.

Nat Genet. 2017 Mar;49(3):444-450. doi: 10.1038/ng.3773. Epub 2017 Jan 23. Erratum in: Nat Genet. 2017 May 26;49(6):970.

20.

Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia.

Fusco N, Bonometti A, Augello C, Fabris S, Boiocchi L, Fiori S, Morotti D, Fracchiolla N, Berti E, Gianelli U.

Histopathology. 2017 May;70(6):1000-1008. doi: 10.1111/his.13166. Epub 2017 Feb 28.

PMID:
28074480
21.

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.

Cutrona G, Matis S, Colombo M, Massucco C, Baio G, Valdora F, Emionite L, Fabris S, Recchia AG, Gentile M, Neumaier CE, Reverberi D, Massara R, Boccardo S, Basso L, Salvi S, Rosa F, Cilli M, Zupo S, Truini M, Tassone P, Calabrese M, Negrini M, Neri A, Morabito F, Fais F, Ferrarini M.

Leukemia. 2017 Sep;31(9):1894-1904. doi: 10.1038/leu.2016.394. Epub 2017 Jan 5.

PMID:
28053325
22.

lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome.

Ronchetti D, Manzoni M, Agnelli L, Vinci C, Fabris S, Cutrona G, Matis S, Colombo M, Galletti S, Taiana E, Recchia AG, Bossio S, Gentile M, Musolino C, Di Raimondo F, Grilli A, Bicciato S, Cortelezzi A, Tassone P, Morabito F, Ferrarini M, Neri A.

Blood Cancer J. 2016 Sep 9;6(9):e468. doi: 10.1038/bcj.2016.77.

23.

Primary Soft Tissue Lymphomas: Description of Seven Cases and Review of the Literature.

Del Gobbo A, Fiori S, Ercoli G, Di Bernardo A, Parafioriti A, Fabris S, Iurlo A, Neri A, Bosari S, Gianelli U.

Pathol Oncol Res. 2017 Apr;23(2):281-286. doi: 10.1007/s12253-016-0096-z. Epub 2016 Aug 1.

PMID:
27480544
24.

Catalytic Proton Dynamics at the Water/Solid Interface of Ceria-Supported Pt Clusters.

Farnesi Camellone M, Negreiros Ribeiro F, Szabová L, Tateyama Y, Fabris S.

J Am Chem Soc. 2016 Sep 14;138(36):11560-7. doi: 10.1021/jacs.6b03446. Epub 2016 Aug 1.

PMID:
27414757
25.

Biological and molecular characterization of a rare case of cutaneous Richter syndrome.

Reda G, Cassin R, Fabris S, Ciceri G, Fattizzo B, Sciumè M, Orofino N, Gianelli U, Neri A, Cortelezzi A.

Hematol Oncol. 2017 Dec;35(4):869-874. doi: 10.1002/hon.2327. Epub 2016 Jul 12.

PMID:
27400669
26.

Effects of Thermal Electronic Excitations on the Diffusion of Oxygen Adatoms on Graphene.

Sun T, Yao X, Fabris S.

J Phys Chem A. 2016 May 5;120(17):2607-13. doi: 10.1021/acs.jpca.6b00423. Epub 2016 Apr 20.

PMID:
27074529
27.
28.

Anagrelide and Mutational Status in Essential Thrombocythemia.

Iurlo A, Cattaneo D, Orofino N, Bucelli C, Fabris S, Cortelezzi A.

BioDrugs. 2016 Jun;30(3):219-23. doi: 10.1007/s40259-016-0170-9.

PMID:
27041108
29.

Creating single-atom Pt-ceria catalysts by surface step decoration.

Dvořák F, Farnesi Camellone M, Tovt A, Tran ND, Negreiros FR, Vorokhta M, Skála T, Matolínová I, Mysliveček J, Matolín V, Fabris S.

Nat Commun. 2016 Feb 24;7:10801. doi: 10.1038/ncomms10801.

30.

Reactivity of atomically dispersed Pt(2+) species towards H2: model Pt-CeO2 fuel cell catalyst.

Lykhach Y, Figueroba A, Camellone MF, Neitzel A, Skála T, Negreiros FR, Vorokhta M, Tsud N, Prince KC, Fabris S, Neyman KM, Matolín V, Libuda J.

Phys Chem Chem Phys. 2016 Mar 21;18(11):7672-9. doi: 10.1039/c6cp00627b.

PMID:
26908194
31.

Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature.

Lionetti M, Barbieri M, Manzoni M, Fabris S, Bandini C, Todoerti K, Nozza F, Rossi D, Musto P, Baldini L, Neri A.

Oncotarget. 2016 Apr 19;7(16):21353-61. doi: 10.18632/oncotarget.7241.

32.

Counting electrons on supported nanoparticles.

Lykhach Y, Kozlov SM, Skála T, Tovt A, Stetsovych V, Tsud N, Dvořák F, Johánek V, Neitzel A, Mysliveček J, Fabris S, Matolín V, Neyman KM, Libuda J.

Nat Mater. 2016 Mar;15(3):284-8. doi: 10.1038/nmat4500. Epub 2015 Dec 14.

PMID:
26657332
33.

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.

Gentile M, Shanafelt TD, Cutrona G, Molica S, Tripepi G, Alvarez I, Mauro FR, Di Renzo N, Di Raimondo F, Vincelli I, Todoerti K, Matis S, Musolino C, Fabris S, Vigna E, Levato L, Zupo S, Angrilli F, Consoli U, Festini G, Longo G, Cortelezzi A, Arcari A, Federico M, Mannina D, Recchia AG, Neri A, Kay NE, Ferrarini M, Morabito F.

Leukemia. 2016 Jun;30(6):1440-3. doi: 10.1038/leu.2015.333. Epub 2015 Dec 9. No abstract available.

PMID:
26648537
34.

Compendium of FAM46C gene mutations in plasma cell dyscrasias.

Barbieri M, Manzoni M, Fabris S, Ciceri G, Todoerti K, Simeon V, Musto P, Cortelezzi A, Baldini L, Neri A, Lionetti M.

Br J Haematol. 2016 Aug;174(4):642-5. doi: 10.1111/bjh.13793. Epub 2015 Oct 12. No abstract available.

PMID:
26456599
35.

Skeletal Muscle an Active Compartment in the Sequestering and Metabolism of Doxorubicin Chemotherapy.

Fabris S, MacLean DA.

PLoS One. 2015 Sep 24;10(9):e0139070. doi: 10.1371/journal.pone.0139070. eCollection 2015.

36.

A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias.

Lionetti M, Barbieri M, Todoerti K, Agnelli L, Fabris S, Tonon G, Segalla S, Cifola I, Pinatel E, Tassone P, Musto P, Baldini L, Neri A.

Oncotarget. 2015 Sep 22;6(28):26129-41. doi: 10.18632/oncotarget.4674.

37.

[The natural story of a mega selection for nurses: a case study].

Picogna M, Fabris S, Palese A.

Assist Inferm Ric. 2015 Apr-Jun;34(2):66-75. doi: 10.1702/1942.21100. Italian.

PMID:
26228503
38.

Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation.

Lionetti M, Barbieri M, Todoerti K, Agnelli L, Marzorati S, Fabris S, Ciceri G, Galletti S, Milesi G, Manzoni M, Mazzoni M, Greco A, Tonon G, Musto P, Baldini L, Neri A.

Oncotarget. 2015 Sep 15;6(27):24205-17.

39.

Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns.

Cifola I, Lionetti M, Pinatel E, Todoerti K, Mangano E, Pietrelli A, Fabris S, Mosca L, Simeon V, Petrucci MT, Morabito F, Offidani M, Di Raimondo F, Falcone A, Caravita T, Battaglia C, De Bellis G, Palumbo A, Musto P, Neri A.

Oncotarget. 2015 Jul 10;6(19):17543-58.

40.

Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.

Maura F, Cutrona G, Mosca L, Matis S, Lionetti M, Fabris S, Agnelli L, Colombo M, Massucco C, Ferracin M, Zagatti B, Reverberi D, Gentile M, Recchia AG, Bossio S, Rossi D, Gaidano G, Molica S, Cortelezzi A, Di Raimondo F, Negrini M, Tassone P, Morabito F, Ferrarini M, Neri A.

Leuk Lymphoma. 2015;56(11):3150-8. doi: 10.3109/10428194.2015.1028051. Epub 2015 May 18.

PMID:
25860243
41.

Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia.

Maura F, Mosca L, Fabris S, Cutrona G, Matis S, Lionetti M, Agnelli L, Barbieri M, D'Anca M, Manzoni M, Colombo M, Massucco C, Reverberi D, Gentile M, Recchia AG, Bossio S, Ilariucci F, Musolino C, Di Raimondo F, Cortelezzi A, Morabito F, Ferrarini M, Neri A.

PLoS One. 2015 Mar 18;10(3):e0118801. doi: 10.1371/journal.pone.0118801. eCollection 2015.

42.

Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.

Gentile M, Cutrona G, Molica S, Ilariucci F, Mauro FR, Di Renzo N, Di Raimondo F, Vincelli I, Todoerti K, Matis S, Musolino C, Fabris S, Lionetti M, Levato L, Zupo S, Angrilli F, Consoli U, Festini G, Longo G, Cortelezzi A, Musto P, Federico M, Neri A, Ferrarini M, Morabito F.

Eur J Haematol. 2016 Jan;96(1):36-45. doi: 10.1111/ejh.12545. Epub 2015 Mar 31.

PMID:
25753656
43.

Predictive power of individual factors and clinical learning experience on academic success: findings from a longitudinal study.

Dante A, Fabris S, Palese A; RIASI group.

Nurse Educ. 2015 May-Jun;40(3):E1-6. doi: 10.1097/NNE.0000000000000132.

PMID:
25643319
44.

Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study.

Morabito F, Cutrona G, Gentile M, Fabris S, Matis S, Vigna E, Todoerti K, Colombo M, Recchia AG, Bossio S, De Stefano L, Ilariucci F, Cortelezzi A, Consoli U, Vincelli I, Pesce EA, Musolino C, Molica S, Di Raimondo F, Neri A, Ferrarini M.

Br J Haematol. 2015 Feb;168(3):455-9. doi: 10.1111/bjh.13117. Epub 2014 Sep 11. No abstract available.

PMID:
25208809
45.
46.

microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.

Negrini M, Cutrona G, Bassi C, Fabris S, Zagatti B, Colombo M, Ferracin M, D'Abundo L, Saccenti E, Matis S, Lionetti M, Agnelli L, Gentile M, Recchia AG, Bossio S, Reverberi D, Rigolin G, Calin GA, Sabbioni S, Russo G, Tassone P, Morabito F, Ferrarini M, Neri A.

Clin Cancer Res. 2014 Aug 1;20(15):4141-53. doi: 10.1158/1078-0432.CCR-13-2497. Epub 2014 Jun 10.

47.

Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.

Gentile M, Cutrona G, Mosca L, Matis S, Fabris S, Lionetti M, Ilariucci F, Zupo S, Musolino C, Levato L, Molica S, Di Raimondo F, Vincelli I, Di Rienzo N, Pesce EA, Angrilli F, Federico M, Neri A, Ferrarini M, Morabito F.

Am J Hematol. 2014 Jul;89(7):743-50. doi: 10.1002/ajh.23729. Epub 2014 Apr 18.

48.

Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.

Hoxha M, Fabris S, Agnelli L, Bollati V, Cutrona G, Matis S, Recchia AG, Gentile M, Cortelezzi A, Morabito F, Bertazzi PA, Ferrarini M, Neri A.

Genes Chromosomes Cancer. 2014 Jul;53(7):612-21. doi: 10.1002/gcc.22171. Epub 2014 Apr 4.

PMID:
24706380
49.

Photoprotective characteristics of natural antioxidant polyphenols.

Stevanato R, Bertelle M, Fabris S.

Regul Toxicol Pharmacol. 2014 Jun;69(1):71-7. doi: 10.1016/j.yrtph.2014.02.014. Epub 2014 Mar 5.

PMID:
24607767
50.

High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.

Lionetti M, Fabris S, Cutrona G, Agnelli L, Ciardullo C, Matis S, Ciceri G, Colombo M, Maura F, Mosca L, Gentile M, Recchia AG, Ilariucci F, Musolino C, Molica S, Di Raimondo F, Cortelezzi A, Rossi D, Gaidano G, Morabito F, Ferrarini M, Neri A.

Br J Haematol. 2014 Jun;165(5):629-39. doi: 10.1111/bjh.12800. Epub 2014 Mar 2.

PMID:
24579978

Supplemental Content

Loading ...
Support Center